DAWN — Day One Biopharmaceuticals, Inc.
Exchange: NASDAQ • IR Tier: D
Subscribe to DAWN Earnings Calendar
http://earningstracker.com/cal/DAWN.ics
Add to Google Calendar
Sentiment Analysis
| Analyzer | Overall | Avg Score | Avg Confidence | Positive | Neutral | Negative | Reports |
|---|---|---|---|---|---|---|---|
| finbert-finbert | positive | 0.69 | 79% | 9 | 4 | 0 | 13 |
| vader | positive | 0.81 | 51% | 12 | 0 | 1 | 13 |
Earnings History
| Period | Date | Timing | Status | Call Time (ET) | EPS | Revenue | Sentiment |
|---|---|---|---|---|---|---|---|
| Q3 2025 | 2026-01-12 | — | CONFIRMED | — | — | $155.4 million | — |
| Q3 2026 | 2026-01-12 | — | CONFIRMED | — | — | — | POSITIVE |
| Q2 2025 | 2025-08-05 | AMC | CONFIRMED | 17:30 EDT * | — | $33.6 million | POSITIVE |
| Q1 2025 | 2025-05-06 | AMC | CONFIRMED | 17:30 EDT * | — | $30.5 million | POSITIVE |
| Q4 2024 | 2025-02-25 | — | CONFIRMED | — | — | — | POSITIVE |
| Q4 2025 | 2025-01-13 | — | CONFIRMED | — | — | $57.2 million | POSITIVE |